Sheridan et al. [68], using breast cancer cell lines with low and high levels of CXCR4 gene expression, found that six major histocompatibility complex (MHC) class II genes were downregulated in cell lines with high levels of CXCR4 expression. The gene discussed is CXCR4; the disease is breast carcinoma.